Physician profile
Carmen Pisc
NPI 1356324453
$716.29
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $226 · 2020: $249 · 2021: $241.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $100.97 | 2020-2021 | |
| Amgen INC. | $78.72 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $72.39 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $68.00 | 2019-2021 | |
| Incyte Corporation | $64.14 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.49 | 2019-2020 | |
| Genzyme Corporation | $41.30 | 2020-2021 | |
| Ipsen Biopharmaceuticals, INC | $35.40 | 2020 | |
| Novartis Pharmaceuticals Corporation | $29.69 | 2019 | |
| Merck Sharp & Dohme LLC | $23.00 | 2021 | |
| Emd Serono, INC. | $20.44 | 2021 | |
| Pharmacyclics LLC, An Abbvie Company | $17.71 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.58 | 2019 | |
| Pfizer INC. | $15.62 | 2020 | |
| Dova Pharmaceuticals | $15.27 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $14.73 | 2020 | |
| Alexion Pharmaceuticals, INC. | $14.36 | 2019 | |
| Seagen INC. | $13.80 | 2019 | |
| Puma Biotechnology, INC. | $13.64 | 2021 | |
| Janssen Biotech, INC. | $13.04 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carmen Pisc listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.